Guardant Health (GH) Tops Q4 EPS by 46c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Guardant Health (GH) Tops Q4 EPS by 46c

Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook

February 23, 2022 4:05 PM EST

Q4 clinical and biopharma volumes up 48% and 36% year over year

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter and year ended December 31, 2021.

Recent Highlights

Revenue of $108 million for the fourth quarter of 2021 and $374 million for the full year 2021, an increase of 38% and 30% over the corresponding period of... More